Sort
39,280 grants matching “leukemia”
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$625,253Thomas J. Kipps · University Of California, San Diego · R01 · FY2023 · CA
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
$625,214Pinkal Desai · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Targeting mitochondrial complex I in acute lymphoblastic leukemia
$625,201Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Aim 4: Target discovery for common disease mechanisms
$625,139Peter Karl Sorger · Harvard Medical School · P50 · FY2014 · GM
Using Mass Spectroscopy to Characterize Transcription Proteins and F2-Isoprostane
$625,117Bettye Henninton · Tougaloo College · P20 · FY2009 · MD
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$625,082Thomas J. Kipps · University Of California, San Diego · R01 · FY2022 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia
$625,049Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2015 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$625,024Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Targeting PRC1 in leukemia
$624,980Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Targeting PRC1 in leukemia
$624,980Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Processed Antigen Characterization by Mass Spectrometry
$624,957Donald F Hunt · University Of Virginia · R01 · FY2016 · AI
SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes
$624,929Mary C. Dasso · Child Health And Human Development · Z01 · FY2007 · HD
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$624,921Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer
$624,828Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$624,783Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Small-molecule MDM2 degraders
$624,777Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Clinical Transplantation Exploiting NK Cell Activity
$624,666Daniel J Weisdorf · University Of Minnesota · P01 · FY2009 · CA
Ezh2-mediated Epigenetic Effects and Alloimmunity
$624,626Yi Zhang · Temple Univ Of The Commonwealth · R01 · FY2016 · HL
Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation
$624,469Edmund K. Waller · Emory University · R01 · FY2024 · AI
Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment
$624,427Marilyn J Hockenberry · Duke University · R01 · FY2012 · CA
Adoptive T-cell Therapies Targeting Mutations in Hematologic Malignancies
$624,367James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Impact of low IL-10 levels at birth and leukemia risk
$624,355Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2016 · CA
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA
$624,345Nancy L Allbritton · University Of Washington · R01 · FY2020 · CA
Protein-RNA interactions in cancer
$624,338Jeremy Robert Sanford · University Of California Santa Cruz · R01 · FY2021 · CA
Clonal hematopoiesis, mild cognitive impairment and kidney function decline
$624,094Michel Benjamin Chonchol · University Of Colorado Denver · R01 · FY2022 · AG